Menu
Search
|

Menu

Close
X

Quotient Ltd QTNT.OQ (NASDAQ Stock Exchange Global Market)

5.90 USD
-0.30 (-4.84%)
As of Nov 14
chart
Previous Close 6.20
Open 6.24
Volume 60,678
3m Avg Volume 66,931
Today’s High 6.29
Today’s Low 5.89
52 Week High 9.02
52 Week Low 2.78
Shares Outstanding (mil) 54.33
Market Capitalization (mil) 336.86
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.33 Mean rating from 3 analysts

KEY STATS

Revenue (mm, USD)
FY19
14
FY18
25
FY17
22
FY16
19
FY15
18
EPS (USD)
FY19
-1.075
FY18
-2.036
FY17
-3.000
FY16
-1.737
FY15
-3.971
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
29.53
Price to Sales (TTM)
vs sector
12.89
22.95
Price to Book (MRQ)
vs sector
--
4.15
Price to Cash Flow (TTM)
vs sector
--
20.94
Total Debt to Equity (MRQ)
vs sector
--
15.47
LT Debt to Equity (MRQ)
vs sector
--
11.13
Return on Investment (TTM)
vs sector
-85.80
13.00
Return on Equity (TTM)
vs sector
--
14.69

EXECUTIVE LEADERSHIP

Heino von Prondzynski
Chairman of the Board, Since 2018
Salary: --
Bonus: --
Edward Farrell
President, Since 2013
Salary: $310,800.00
Bonus: $155,400.00
Jeremy Stackawitz
President, Since 2009
Salary: $318,150.00
Bonus: $421,141.00
Franz Walt
Chief Executive Officer, Director, Since 2018
Salary: --
Bonus: --
Christopher Lindop
Chief Financial Officer, Principal Financial Officer, Since 2017
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

28 Esplanade
SAINT HELIER     JE2 3QA

Phone: +44131.4456159

Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. It is engaged in developing MosaiQ, which is its technology platform. The Company develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Its antisera products contain antibodies used to identify blood group antigens. Its antisera products are monoclonal antibodies manufactured from master cell lines it owns. Its reagent red blood cells products are composed of human red blood cells formulated to enable the identification of blood group antibodies. The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).

SPONSORED STORIES